Gene Synthesis Global Market Report 2023: Advent of Enzymatic DNA Synthesis Process Boosts Growth
February 16, 2023 08:48 ET
|
Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Gene Synthesis Market Size, Share & Trends Analysis Report By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By...
Advances in Gene Editing Technologies in Healthcare, 2023 Research Report - Next-Generation Genome Editing Tools and Improved Delivery Are Bolstering Gene Editing Therapeutics and Diagnostics
February 10, 2023 10:53 ET
|
Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Advances in Gene Editing Technologies in Healthcare" report has been added to ResearchAndMarkets.com's offering. CRISPR, ZFNs, and TALENs are...
CRISPR Technology Global Markets Report 2023: A $9.2 Billion Market by 2027, from $3.3 Billion in 2022
January 25, 2023 04:08 ET
|
Research and Markets
Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The "CRISPR Technology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report provides detailed exposure to the...
Synthetic Biology Market through Healthcare Sector to grow at 30% CAGR in Next 10 Years, Reveals Persistence Market Research
January 17, 2023 10:30 ET
|
Persistence Market Research
New York, Jan. 17, 2023 (GLOBE NEWSWIRE) -- As per the latest report published by Persistence Market Research, a leading Market Research firm, the Synthetic Biology Market was valued at US$ 9.8...
Genome Engineering Global Market Report 2022: Increasing Funding and Investments for Research and Development Present Lucrative Opportunities
December 08, 2022 06:08 ET
|
Research and Markets
Dublin, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The "Genome Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Technology (CRISPR, TALEN, ZFN,...
U.S. Gene Editing Market Report 2022: Increasing Demand for Synthetic Genes Boosts Growth
November 16, 2022 04:48 ET
|
Research and Markets
Dublin, Nov. 16, 2022 (GLOBE NEWSWIRE) -- The "U.S. Gene Editing Market - Industry Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.The U.S. gene editing...
CRISPR and CAS Genes Global Market to Expand by 26.82% Yearly Through 2029
November 07, 2022 05:40 ET
|
Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "CRISPR and CAS Genes Market Analysis by Product & Service, by Application by End user, and by Region - Global Forecast to 2029" report has been...
Global CRISPR Technology Intellectual Property Landscape Report 2022: Identify Key Trends that Describe the Pace and Focus of Innovation Related to CRISPR / CAS Technologies
October 18, 2022 08:53 ET
|
Research and Markets
Dublin, Oct. 18, 2022 (GLOBE NEWSWIRE) -- The "CRISPR Technologies: Intellectual Property Landscape(Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent...
Outlook on the Cell Therapy Global Market to 2028 - Increased Demand for Novel, Better Medicines for Diseases Such as Cancer and CVD Has Resulted in an Increase in General Research Efforts
October 05, 2022 07:08 ET
|
Research and Markets
Dublin, Oct. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Market, By Use Type, By Therapy Type, By Product, By Technology & By Region- Forecast and Analysis 2022-2028" report has been...
Intellia and Regeneron Announce Initial Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis
September 16, 2022 07:15 ET
|
Intellia Therapeutics, Inc.
Interim data from the cardiomyopathy arm of the Phase 1 study of NTLA-2001 showed deep and sustained mean serum transthyretin (TTR) reductions of 93% and 92% at 0.7 mg/kg and 1.0 mg/kg doses,...